首页> 外文期刊>European journal of human genetics: EJHG >Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population
【24h】

Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population

机译:与芬兰人群中的奇异体额发射术潜在的额外颞型术前术的表型谱

获取原文
获取原文并翻译 | 示例
       

摘要

Intellectual disability (ID), megalencephaly, frontal predominant pachygyria, and seizures, previously called "thin" lissencephaly, are reported to be caused by recessive variants in CRADD. Among five families of different ethnicities identified, one homozygous missense variant, c.509G>A p.(Argl70His), was of Finnish ancestry. Here we report on the phenotypic variability associated for this potential CRADD founder variant in 22 Finnish individuals. Exome sequencing was used to identify candidate genes in Finnish patients presenting with ID. Targeted Sanger sequencing and restriction enzyme analysis were applied to screen for the c.509G>A CRADD variant in cohorts from Finland. Detailed phenotyping and genealogical studies were performed. Twenty two patients were identified with the c.509G>A p.(Argl70His) homozygous variant in CRADD. The majority of the ancestors originated from Northeastern Finland indicating a founder effect. The hallmark of the disease is frontotemporal predominant pachygyria with mild cortical thickening. All patients show ID of variable severity. Aggressive behavior was found in nearly half of the patients, EEG abnormalities in five patients and megalencephaly in three patients. This study provides detailed data about the phenotypic spectrum of patients with lissencephaly due to a CRADD variant that affects function. High inter- and intrafamilial phenotypic heterogeneity was identified in patients with pachygyria caused by the homozygous CRADD founder variant. The phenotype variability suggests that additional genetic and/or environmental factors play a role in the clinical presentation. Since frontotemporal pachygyria is the hallmark of the disease, brain imaging studies are essential to support the molecular diagnosis for individuals with ID and a CRADD variant.
机译:据报道,智力残疾(ID),Mugalience,Frontal Pervinant Pachygyria和癫痫发作,以前称为“薄”的植物疫苗,据报道是由Cradd中的隐性变体引起的。在鉴定的五个不同种族的家庭中,一个纯合物的小姐变种,C.509g> a p。(argl70his),是芬兰血统。在这里,我们报告了22名芬兰人的潜在Cradd创始人变体相关的表型变异性。 exome测序用于鉴定芬兰患者的候选基因,其呈现ID。将靶向的Sanger测序和限制性酶分析应用于来自芬兰的C.509G> C.509G> C.509G的C.509G的筛选。进行详细的表型和族学研究。用C.509g> A p。(Arg170His)纯合子变异在CRADD中鉴定了二十两名患者。大多数祖先起源于芬兰东北部,表明创始人效应。该疾病的标志是额定颞常常的Pachygyria,具有温和的皮质增厚。所有患者均显示可变严重程度的ID。在近一半的患者中发现了侵略性行为,三名患者的脑电图异常和三名患者的Megalence。本研究提供了关于由于影响功能的CRASINGS患者患者的表型谱的详细数据。在纯合的CRADD创始人变体引起的术患者中,鉴定了高间相和中的表型异质性。表型变异性表明,额外的遗传和/或环境因素在临床介绍中发挥作用。由于前兆术术是疾病的标志,脑成像研究对于支持ID和CRADD变体的个体的分子诊断至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号